Exploring the molecular mechanism of gan shuang granules for the treatment of non-alcoholic steatohepatitis using network pharmacology, molecular docking, and experimental veri cation

HIGHLIGHTS

  • who: January and colleagues from the University of Texas MD Anderson Cancer Center, United States have published the Article: Exploring the molecular mechanism of Gan Shuang granules for the treatment of non-alcoholic steatohepatitis using network pharmacology, molecular docking, and experimental veri cation, in the Journal: (JOURNAL)
  • what: To further meet the purpose of this experimental study, only the top 20 pathway information was taken to plot the bar chart . 3.10 GSG protects the liver from CDHFDinduced inflammatory evidence, liver injury and liver fibrosis To further investigate the effect of GSG on the pathology . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?